QA: CAMBREX CORP in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2018_CAMBREX_CORP.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000820081')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000820081, CAMBREX CORP

  xvar xval
0 AssetsCurrent 422,078,000
1 IntangibleAssetsNetIncludingGoodwill 57,494,000
2 PropertyPlantAndEquipmentNet 254,299,000
3 remainder_Assets 6,694,000
4 LiabilitiesCurrent 82,541,000
5 LiabilitiesNoncurrent 25,213,000
6 remainder_Liabilities 87,947,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 70,468,000
9 ResearchAndDevelopmentExpense 16,901,000
10 remainder_Expenses 342,430,000
11 remainder_Revenues 534,456,000
12 remainder_NetIncome -2,207,000
13 remainder_ComprehensiveNetIncome 23,292,000
  yvar yval
0 Assets 740,565,000
1 Liabilities 195,701,000
2 Expenses 429,799,000
3 Revenues 534,456,000
4 StockholdersEquity 544,864,000
5 NetIncome 102,450,000
6 ComprehensiveNetIncome 114,096,000
7 BaseVar 963,010,000
8 EconomicCapitalRatio 2.25

Edgar->Model Mapping

Feature Distribution

Change over Time